Active, not recruitingPhase 1NCT06545110

Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
South Valley University
Principal Investigator
Mostafa Adam Ali El Tieb, professor
Aswan University
Intervention
Baricitinib Oral Tablet(drug)
Enrollment
120 enrolled
Eligibility
12-60 years · All sexes
Timeline
20232024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06545110 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials